These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4914782)

  • 1. [A study of the homozygosity of congenic strain B10.D2 mice by the skin graft method].
    Egorov IK
    Biull Eksp Biol Med; 1967 May; 63(5):104-6. PubMed ID: 4914782
    [No Abstract]   [Full Text] [Related]  

  • 2. Histoincompatibility between the B10.D2-n and B10.D2-0 strains of mice.
    Kaliss N; Bailey DW; Shin HS
    Transplantation; 1972 Oct; 14(4):523-5. PubMed ID: 4566169
    [No Abstract]   [Full Text] [Related]  

  • 3. The mixed lymphocyte reaction. Detection of single histocompatibility loci and the correlation to skin graft survival in mice.
    Mangi RJ; Mardiney MR
    Transplantation; 1971 Apr; 11(4):369-73. PubMed ID: 4934347
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of mixed lymphocyte reaction and its correlation with skin graft survival.
    Mangi RJ; Mardiney MR
    Transplant Proc; 1971 Mar; 3(1):873-5. PubMed ID: 4937984
    [No Abstract]   [Full Text] [Related]  

  • 5. Strain C57BL-10ScSn and its congenic resistant sublines.
    Stimpfling JH; Reichert AE
    Transplant Proc; 1970 Mar; 2(1):39-47. PubMed ID: 4940354
    [No Abstract]   [Full Text] [Related]  

  • 6. The survival time of two skin grafts differing in histocompatibility antigens in mice.
    Sankowski A; Taczanowski W; Obrowska D
    Folia Biol (Praha); 1971; 17(6):418-20. PubMed ID: 4944670
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic control of the antibody response to simple haptens in congenic strains of mice.
    Rathbun WE; Hildemann WH
    J Immunol; 1970 Jul; 105(1):98-107. PubMed ID: 4912961
    [No Abstract]   [Full Text] [Related]  

  • 8. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
    Rodríguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M
    Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histocompatibility typing of inbred mice for known non-H-2 alleles.
    Graff RJ; Snell GD
    Transplant Proc; 1969 Mar; 1(1):362-4. PubMed ID: 4944240
    [No Abstract]   [Full Text] [Related]  

  • 14. Histocompatibility antigens and transplantation.
    Batchelor JR
    Trans Med Soc Lond; 1969; 85():68-73. PubMed ID: 4903133
    [No Abstract]   [Full Text] [Related]  

  • 15. A new minor histocompatibility locus linked to H-3.
    Click RE; Schneider D; Roopenian DC
    J Immunol; 1981 Jun; 126(6):2378-81. PubMed ID: 7229381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses to alloantigens. IV. In vivo and in vitro studies of the abrogation of presensitization to major histocompatibility antigens.
    Burton RC; Fortin JL; Aversano RC; Russell PS
    Transplantation; 1982 Apr; 33(4):339-46. PubMed ID: 7041359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin graft rejection between subjects genotyped for HL-A.
    Amos DB; Seigler HF; Southworth JG; Ward FE
    Transplant Proc; 1969 Mar; 1(1):342-6. PubMed ID: 4944238
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
    Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
    Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.